PRJNA431826
NGS on the 5BP correction followed by genome editing therapy
The studied mouse model have a 5BP deletion in the RPGR gene and CRISPR/Cas9-mediated in vivo genome editing therapy was designed to repair it. The next-generation sequencing is done to verify the 5BP correction.The results show homology-directed repair in the target site.